Sanofi (SNYNF)
OTC: SNYNF
· Real-Time Price · USD
100.88
-0.30 (-0.30%)
At close: Aug 19, 2025, 3:28 PM
100.88
0.00%
After-hours: Aug 19, 2025, 04:00 PM EDT
Sanofi Cash Flow Statement
Financials in EUR. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 4.61B | 5.74B | 7.03B | 6.74B | 9.06B | 9.92B | 13.14B | 12.69B | 12.44B | 12.46B | 10.72B | 10.96B | 10.55B | 10.11B | 9.69B | 9.33B | 15.83B |
Depreciation & Amortization | n/a | n/a | 2.99B | 2.99B | 4.85B | 4.85B | 3.47B | 3.47B | 3.44B | 3.44B | 3.46B | 3.46B | 3.36B | 3.36B | 3.41B | 3.41B | 3.69B |
Stock-Based Compensation | 173M | 173M | 456M | 456M | 443M | 443M | 405M | 405M | 389M | 389M | 388M | 388M | 378M | 378M | 408M | 408M | 442M |
Other Working Capital | -1.85B | -1.85B | -325M | -325M | 1.6B | 1.6B | 667M | 667M | 545M | 545M | 387M | 387M | 1.13B | 1.13B | 572M | 572M | 316M |
Other Non-Cash Items | -2.69B | -5.92B | 1.37B | 1.66B | 7.09B | 6.23B | 2.85B | 3.3B | 4.06B | 4.05B | 3.69B | 3.44B | 2B | 2.45B | 1.41B | 1.77B | -3.51B |
Deferred Income Tax | n/a | n/a | -524M | -524M | -970M | -970M | -620M | -620M | -578M | -578M | -626M | -626M | -356M | -356M | -52M | -52M | -214M |
Change in Working Capital | n/a | n/a | 1.58B | 1.58B | 764M | 764M | -484M | -484M | -707M | -707M | -168M | -168M | 1.41B | 1.41B | 604M | 604M | -325M |
Operating Cash Flow | 2.09B | n/a | 6.7B | 6.7B | 10.26B | 10.26B | 10.26B | 10.26B | 10.53B | 10.53B | 9.59B | 9.59B | 10.52B | 10.52B | 8.28B | 8.28B | 7.45B |
Capital Expenditures | -1.93B | -1.93B | -4.04B | -4.04B | -3.25B | -3.25B | -2.35B | -2.35B | -2.22B | -2.22B | -2.11B | -2.11B | -2.11B | -2.11B | -2.56B | -2.56B | -2.23B |
Cash Acquisitions | n/a | n/a | 437M | 437M | 1.01B | 1.01B | 1.64B | 1.64B | 630M | 630M | -4.09B | -4.09B | -4.88B | -4.88B | -3.99B | -3.99B | -4.42B |
Purchase of Investments | n/a | n/a | -1.48B | -1.48B | -4B | -4B | -2.9B | -2.9B | -488M | -488M | -350M | -350M | -311M | -311M | -191M | -191M | -137M |
Sales Maturities Of Investments | n/a | n/a | 27M | 27M | 42M | 42M | -86M | -86M | n/a | n/a | 101M | 101M | n/a | n/a | -142M | -142M | 10.37B |
Other Investing Acitivies | -3.82B | -3.04B | -3.04B | -3.04B | n/a | n/a | n/a | n/a | n/a | n/a | 29M | 29M | n/a | n/a | 58M | 58M | n/a |
Investing Cash Flow | -3.82B | -3.04B | -6.17B | -6.17B | -6.2B | -6.2B | -3.69B | -3.69B | -2.08B | -2.08B | -6.42B | -6.42B | -7.3B | -7.3B | -6.83B | -6.83B | 3.59B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -302M | -302M | -532M | -532M | -593M | -593M | -500M | -500M | -497M | -497M | -602M | -602M | -382M | -382M | -601M | -601M | -822M |
Dividend Paid | n/a | n/a | n/a | n/a | -4.45B | -4.45B | -4.45B | -4.45B | -4.17B | -4.17B | -4.17B | -4.17B | -4.01B | -4.01B | -4.01B | -4.01B | -3.94B |
Other Financial Acitivies | -1.26B | -671M | -3.51B | -3.51B | -3.6B | -3.6B | -973M | -973M | -1.65B | -1.65B | -1.44B | -1.44B | -2.62B | -2.62B | -3.69B | -3.69B | -1.09B |
Financial Cash Flow | -1.26B | -671M | -3.51B | -3.51B | -8.05B | -8.05B | -5.43B | -5.43B | -5.82B | -5.82B | -6.04B | -6.04B | -7.06B | -7.06B | -7.7B | -7.7B | -6.49B |
Net Cash Flow | -1.84B | -2.39B | -1.67B | -1.67B | -4.03B | -4.03B | 1.09B | 1.09B | 2.64B | 2.64B | -2.82B | -2.82B | -3.82B | -3.82B | -6.25B | -6.25B | 4.17B |
Free Cash Flow | 1.59B | -504M | 4.08B | 4.08B | 7B | 7B | 7.92B | 7.92B | 8.31B | 8.31B | 7.48B | 7.48B | 8.41B | 8.41B | 5.71B | 5.71B | 5.22B |